Metabolic Pathway Independence Because Semaglutide and Tesamorelin work through completely different receptor systems and metabolic pathways, they do not interfere with each other
Moderator: - Talita Ferreira, Latin America Biowaiver Project Manager, International Pharmaceutical Federation (FIP) - Brazil Panellists: - Maria del Val (Marival) Bermejo Sanz, Professor, Miguel Hernndez University - Spain - Isabel Gonzlez, Professor, Miguel Hernndez University - Spain - Gladys Granero, Professor, University of Crdoba - Argentina - Pablo Gonzlez, CEO, Innovation and Biopharmaceutical Evaluation Center, Chile - Miguel Angel Cabrera-Prez, Associate Professor, Central University of Las Villas, Cuba Watch video Digital event video 12 October 2021, 15:00 - 16:30 CEST FIP WiSE: Women in science and education: Launch of the enabling workplace toolkit More Building on World Health Professions Alliance (WHPA), Positive Practice Environments Campaign, the FIPWiSE toolkit for positive practice environments in education & science is developed to identify and address inequalities in the workplace environments which affects women in pharmaceutical science and pharmacy education, with transferable learnings across the pharmaceutical workforce
For skin specifically, GHK-Cu has become one of the most studied peptides in cosmetic dermatology
Semaglutide is a proven, FDA-approved GLP-1 agonist for weight loss (1520% body weight reduction in clinical trials) Tirzepatide is a dual GIP/GLP-1 agonist showing up to 22% weight loss in trials often more potent than Semaglutide for some patients Retatrutide is an experimental triple agonist with promising early results, but is NOT FDA-approved and not yet available at Better Med Spa All three require medical supervision, lifestyle changes, and ongoing monitoring for safe, sustainable results Better Med Spa in Lincoln Park currently offers Semaglutide and Tirzepatide with physician-directed protocols, slow titration, and holistic wellness integration Quick Comparison: Semaglutide vs
